Succeed with Sirion – clinically proven poloxamer, LentiBOOST®

SIRION’s clinically proven poloxamer, LentiBOOST®, can significantly improve lentiviral CD34+ HSC transduction protocols with the potential to improve production of gene-modified cell products, found Ilona Hauber and colleagues, including some researchers from SIRION. Read the full paper here: https://bit.ly/Sir59